Feng Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Feng Pan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Nan Yang
6 shared publicationsSanhua Li
6 shared publicationsKunmei Li
5 shared publicationsGejie Shi
3 shared publications- Yun Liu
The Key Laboratory of Pharmaceutical Research for Tumor Prevention and Treatment of the Education Department of Guizhou Province Zunyi Medical University Zunyi China
3 shared publications Binxin Zhao
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Tsinghua University Press in Food Science and Human Wellness
Neutral Polysaccharide from Bletilla striata (Thunb. ex A. Murray) Rchb. f. Alleviates Liver Fibrosis through Modulation of TGF- β /SMAD Signaling Axis and Remodeling of Gut Microbiota
Hepatic fibrosis remains a global health concern that urgently requires development of new anti-fibrotic compounds with high efficacy and low toxicity. Bletilla striata, known for its high polysaccharide content and well-established safety profile, shows therapeutic potential. In this study, we isolated a novel neutral glucomannan (BsPsIII1-1, approximately 74.8 kDa) from B. striata. Structural analysis showed that the proposed main chain repeating unit was →{4)-β-D-Glcp-(1}x→{4)-β-D-Manp-(1}n→{4)-β-D-Glcp-(1}y→4)-β-D-2Ac-Manp-(1→4)-β-D-3Ac-Manp-(1→4)-β-D-2Ac-Manp-(1→{4)-β-D-Manp-(1}m→4)-β-D-3Ac-Manp-(1→{4)-β-D-Manp-(1}i→ (where x+y=8 and n+m+i=4). BsPsIII1-1 attenuated hepatic fibrosis both in vitro, by reducing TGF-β1-induced α-smooth muscle actin (α-SMA) and collagen type I (COL-1) in LX2 cells, and in vivo, by mitigating CCl₄-induced weight loss, AST and ALT elevation, and hepatic MDA and GSH imbalance in mice, with histopathology confirming decreased collagen deposition. Mechanistically, BsPsIII1-1 inhibited TGF-β/SMAD signaling by inhibiting TGF-β1 secretion, suppressing phosphorylation of SMAD2 and SMAD4, and increasing SMAD7. It also modulated gut microbiota by enhancing beneficial bacteria, suppressing pathogens, and promoting production of short-chain fatty acids. These actions synergistically downregulated α-SMA and COL-1 through the gut-liver axis and TGF-β/SMAD signaling. In our study, we identified BsPsIII1-1, a novel biomacromolecule isolated from B. striata, as a potential anti-fibrotic agent with hepatoprotective properties, demonstrating promise as a functional food or therapeutic candidate for the treatment of fibrotic liver diseases.
- 29 September 2026
- Published by Tsinghua University Press in Food Science and Human Wellness
Open AccessNeutral Polysaccharide from Bletilla striata (Thunb. ex A. Murray) Rchb. f. Alleviates Liver Fibrosis through Modulation of TGF- β /SMAD Signaling Axis and Remodeling of Gut Microbiota
Hepatic fibrosis remains a global health concern that urgently requires development of new anti-fibrotic compounds with high efficacy and low toxicity. Bletilla striata, known for its high polysaccharide content and well-established safety profile, shows therapeutic potential. In this study, we isolated a novel neutral glucomannan (BsPsIII1-1, approximately 74.8 kDa) from B. striata. Structural analysis showed that the proposed main chain repeating unit was →{4)-β-D-Glcp-(1}x→{4)-β-D-Manp-(1}n→{4)-β-D-Glcp-(1}y→4)-β-D-2Ac-Manp-(1→4)-β-D-3Ac-Manp-(1→4)-β-D-2Ac-Manp-(1→{4)-β-D-Manp-(1}m→4)-β-D-3Ac-Manp-(1→{4)-β-D-Manp-(1}i→ (where x+y=8 and n+m+i=4). BsPsIII1-1 attenuated hepatic fibrosis both in vitro, by reducing TGF-β1-induced α-smooth muscle actin (α-SMA) and collagen type I (COL-1) in LX2 cells, and in vivo, by mitigating CCl₄-induced weight loss, AST and ALT elevation, and hepatic MDA and GSH imbalance in mice, with histopathology confirming decreased collagen deposition. Mechanistically, BsPsIII1-1 inhibited TGF-β/SMAD signaling by inhibiting TGF-β1 secretion, suppressing phosphorylation of SMAD2 and SMAD4, and increasing SMAD7. It also modulated gut microbiota by enhancing beneficial bacteria, suppressing pathogens, and promoting production of short-chain fatty acids. These actions synergistically downregulated α-SMA and COL-1 through the gut-liver axis and TGF-β/SMAD signaling. In our study, we identified BsPsIII1-1, a novel biomacromolecule isolated from B. striata, as a potential anti-fibrotic agent with hepatoprotective properties, demonstrating promise as a functional food or therapeutic candidate for the treatment of fibrotic liver diseases.
- 9 April 2026
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 106 (10) , 6015-6028
Extraction, isolation, structural characterization, antioxidant activity and cardiomyocyte protective activity of polysaccharide from Bletilla striata leaves
BACKGROUND: Although tuber polysaccharides of Bletilla striata have been extensively studied, the leaf polysaccharides, which constitute over 25% of the plant's biomass, are frequently discarded as agricultural waste. Given the well‐documented bioactivities of plant polysaccharides, this represents significant untapped potential. Current cardioprotective agents exhibit limitations against doxorubicin‐induced cardiotoxicity, creating demand for novel natural alternatives. This study thus aimed to isolate and characterize the primary polysaccharide from B. striata leaves and evaluate its antioxidant capacity and cardioprotective effects, thereby converting this agricultural waste into a therapeutic agent. RESULTS: The purified homogeneous polysaccharide BSP‐L2‐1 (Mw > 500 kDa) was structurally characterized as a highly branched heteropolysaccharide featuring triple‐helix conformation, with a mannose:galacturonic acid:glucose:galactose:arabinose molar ratio of 6.02:1.74:2.70:10.00:4.32. In vitro assays demonstrated potent antioxidant activity, with BSP‐L2‐1 achieving 72.37% inhibition of ABTS radicals at a concentration of 6 mg mL −1 . More notably, in a doxorubicin‐injured H9c2(2‐1) cardiomyocytes model, BSP‐L2‐1 exhibited significant cardioprotection by suppressing reactive oxygen species and malondialdehyde overproduction, enhancing glutathione and superoxide dismutase activity and concurrently preserving mitochondrial function. Additionally, toxicity assessments in a zebrafish model confirmed no observable adverse effects across a broad concentration range (100–900 μg mL −1 ). CONCLUSION: BSP‐L2‐1, a novel acidic natural polysaccharide isolated from underutilized B. striata leaves, mitigated doxorubicin‐induced cardiotoxicity by attenuating oxidative stress and preserving mitochondrial function. These findings support its development as a natural adjuvant to prevent doxorubicin‐induced cardiotoxicity, with potential applications ranging from functional foods to pharmaceutical formulations. © 2026 Society of Chemical Industry.
- 9 April 2026
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 106 (10) , 6015-6028
Extraction, isolation, structural characterization, antioxidant activity and cardiomyocyte protective activity of polysaccharide from Bletilla striata leaves
BACKGROUND: Although tuber polysaccharides of Bletilla striata have been extensively studied, the leaf polysaccharides, which constitute over 25% of the plant's biomass, are frequently discarded as agricultural waste. Given the well‐documented bioactivities of plant polysaccharides, this represents significant untapped potential. Current cardioprotective agents exhibit limitations against doxorubicin‐induced cardiotoxicity, creating demand for novel natural alternatives. This study thus aimed to isolate and characterize the primary polysaccharide from B. striata leaves and evaluate its antioxidant capacity and cardioprotective effects, thereby converting this agricultural waste into a therapeutic agent. RESULTS: The purified homogeneous polysaccharide BSP‐L2‐1 (Mw > 500 kDa) was structurally characterized as a highly branched heteropolysaccharide featuring triple‐helix conformation, with a mannose:galacturonic acid:glucose:galactose:arabinose molar ratio of 6.02:1.74:2.70:10.00:4.32. In vitro assays demonstrated potent antioxidant activity, with BSP‐L2‐1 achieving 72.37% inhibition of ABTS radicals at a concentration of 6 mg mL −1 . More notably, in a doxorubicin‐injured H9c2(2‐1) cardiomyocytes model, BSP‐L2‐1 exhibited significant cardioprotection by suppressing reactive oxygen species and malondialdehyde overproduction, enhancing glutathione and superoxide dismutase activity and concurrently preserving mitochondrial function. Additionally, toxicity assessments in a zebrafish model confirmed no observable adverse effects across a broad concentration range (100–900 μg mL −1 ). CONCLUSION: BSP‐L2‐1, a novel acidic natural polysaccharide isolated from underutilized B. striata leaves, mitigated doxorubicin‐induced cardiotoxicity by attenuating oxidative stress and preserving mitochondrial function. These findings support its development as a natural adjuvant to prevent doxorubicin‐induced cardiotoxicity, with potential applications ranging from functional foods to pharmaceutical formulations. © 2026 Society of Chemical Industry.
- 5 January 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (2) , 82
Research progress in plant endophyte-mediated lignocellulosic biomass degradation and valorization: a review
- 5 January 2026
- Published by Springer Nature in Archives of Microbiology
- Vol. 208 (2) , 82
Research progress in plant endophyte-mediated lignocellulosic biomass degradation and valorization: a review
- Open Access
- 1 September 2025
- Published by Springer Nature in Chemical and Biological Technologies in Agriculture
- Vol. 12 (1) , 1-24
Structural characterization, antioxidant and antitumor properties of an acidic polysaccharide from toad venom
- 1 September 2025
- Published by Springer Nature in Chemical and Biological Technologies in Agriculture
- Vol. 12 (1) , 1-24
Open AccessStructural characterization, antioxidant and antitumor properties of an acidic polysaccharide from toad venom
- 27 April 2024
- Published by Springer Nature in Physiology and Molecular Biology of Plants
- Vol. 30 (4) , 619-631
Evaluation of volatile components from the tuber, fibrous roots, bud, stem and leaf tissues of Bletilla striata for its anti-colon cancer activity
Bletilla striata (Thunb.) Rchb.f., a medicinal plant in the Orchidaceae family, is mainly found in East Asia and has extensive pharmacological activities. Plant's volatile components are important active ingredients with a wide range of physiological activities, and B. striata has a special odor and unique volatile components. Yet it has received little attention, hindering a full understanding of its phytochemical components. Employing the ultrasonic-assisted extraction method, the volatile components of B. striata's fibrous root, bud, aerial part and tuber were extracted, resulting in yields of 0.06%, 0.64%, 3.38% and 4.47%, respectively. A total of 78 compounds were identified from their chemical profiles using gas chromatography-mass spectrometry (GC–MS), including 45 components with the main compounds of linoleic acid (content accounting for 31.23%), n-hexadecanoic acid (13.53%), and octadecanoic acid (9.5%) from the tuber, 34 components with the main compounds of eicosane, 2-methyl- (28.42%), linoelaidic acid (10.43%), linoleic acid (4.53%), and n-hexadecanoic acid (6.91%) from the fibrous root, 38 components with the main compounds of pentadeca-6,9-dien-1-ol (9.29%), n-hexadecanoic acid (11%), eicosane,2-methyl- (23.43%), and linoleic acid (23.53%) from the bud, and 27 components with the main compounds of linoelaidic acid (5.97%), n-hexadecanoic acid (15.99%), and linolenic acid ethyl ester (18.9%) from the aerial part. Additionally, the growth inhibition activity against colon cancer HCT116 cells was evaluated using sulforhodamine B (SRB) assay and the thiazolyl blue tetrazolium bromide (MTT) assay, and the accumulation of reactive oxygen species (ROS) was determined using dichloro-dihydro-fluorescein diacetate (DCFH-DA) staining and fluorescence intensity analysis. The volatile extracts exhibited significant growth inhibitory efficacy against HCT116 cells, with half-maximal inhibitory concentration (IC50) values of 3.65, 2.32, 2.42 and 3.89 mg/mL in the SRB assay, and 3.55, 2.58, 3.12 and 4.80 mg/mL in the MTT assay for the root, bud, aerial part, and tuber, respectively. Notably, treatment with the aerial part extract caused morphological changes in the cells and significantly raised the intracellular ROS level. In summary, the chemical profiles of the volatile components of B. striata were revealed for the first time, demonstrating a certain tissue specificity. Additionally, it demonstrated for the first time that these volatile extracts possess potent anti-colon cancer activity, highlighting the importance of these volatile components in B. striata's medicinal properties.
- 27 April 2024
- Published by Springer Nature in Physiology and Molecular Biology of Plants
- Vol. 30 (4) , 619-631
Evaluation of volatile components from the tuber, fibrous roots, bud, stem and leaf tissues of Bletilla striata for its anti-colon cancer activity
Bletilla striata (Thunb.) Rchb.f., a medicinal plant in the Orchidaceae family, is mainly found in East Asia and has extensive pharmacological activities. Plant's volatile components are important active ingredients with a wide range of physiological activities, and B. striata has a special odor and unique volatile components. Yet it has received little attention, hindering a full understanding of its phytochemical components. Employing the ultrasonic-assisted extraction method, the volatile components of B. striata's fibrous root, bud, aerial part and tuber were extracted, resulting in yields of 0.06%, 0.64%, 3.38% and 4.47%, respectively. A total of 78 compounds were identified from their chemical profiles using gas chromatography-mass spectrometry (GC–MS), including 45 components with the main compounds of linoleic acid (content accounting for 31.23%), n-hexadecanoic acid (13.53%), and octadecanoic acid (9.5%) from the tuber, 34 components with the main compounds of eicosane, 2-methyl- (28.42%), linoelaidic acid (10.43%), linoleic acid (4.53%), and n-hexadecanoic acid (6.91%) from the fibrous root, 38 components with the main compounds of pentadeca-6,9-dien-1-ol (9.29%), n-hexadecanoic acid (11%), eicosane,2-methyl- (23.43%), and linoleic acid (23.53%) from the bud, and 27 components with the main compounds of linoelaidic acid (5.97%), n-hexadecanoic acid (15.99%), and linolenic acid ethyl ester (18.9%) from the aerial part. Additionally, the growth inhibition activity against colon cancer HCT116 cells was evaluated using sulforhodamine B (SRB) assay and the thiazolyl blue tetrazolium bromide (MTT) assay, and the accumulation of reactive oxygen species (ROS) was determined using dichloro-dihydro-fluorescein diacetate (DCFH-DA) staining and fluorescence intensity analysis. The volatile extracts exhibited significant growth inhibitory efficacy against HCT116 cells, with half-maximal inhibitory concentration (IC50) values of 3.65, 2.32, 2.42 and 3.89 mg/mL in the SRB assay, and 3.55, 2.58, 3.12 and 4.80 mg/mL in the MTT assay for the root, bud, aerial part, and tuber, respectively. Notably, treatment with the aerial part extract caused morphological changes in the cells and significantly raised the intracellular ROS level. In summary, the chemical profiles of the volatile components of B. striata were revealed for the first time, demonstrating a certain tissue specificity. Additionally, it demonstrated for the first time that these volatile extracts possess potent anti-colon cancer activity, highlighting the importance of these volatile components in B. striata's medicinal properties.
- Open Access
- 19 January 2024
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 10
Six bufadienolides derivatives are the main active substance against human colorectal cancer HCT116 cells of Huachansu injection
- 19 January 2024
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 10
Open AccessSix bufadienolides derivatives are the main active substance against human colorectal cancer HCT116 cells of Huachansu injection
- 3 August 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (32) , 12190-12202
Discovery of a Natural Hybrid Polyketide Produced by Endophytic Cladosporium sphaerospermum for Biocontrol of Phytopathogenic Fungus Botrytis cinerea
The endophytic fungus Cladosporium sphaerospermum WBS017 exhibits broad-spectrum activity against plant pathogens, with particular effectiveness against Botrytis cinerea. Subsequently, a compound is isolated from strain WBS017 as the main active ingredient against B. cinerea using activity-guided separation and identified as hybrid polyketide (namely cladodionen, CLD) using UV, MS, NMR, etc. In vitro and in vivo antifungal activity tests demonstrate that CLD effectively inhibits the mycelial growth and spore germination, with an IC50 value of 1.13 and 0.095 mM, respectively, and exerts antifungal and fresh-keeping effects on both strawberry and tomato. Microscopy analysis reveals that the inhibitory effects of CLD on hyphae and spore germination are attributed to a decrease in structural stability of mycelia cells as well as the accumulation of reactive oxygen species (ROS). Furthermore, transcriptome analysis further indicates that spore germination is inhibited by suppressing the transcription levels of membrane or membrane-related genes, disturbing the balance of ROS metabolism, altering the primary metabolic pathways, genetic information processing, and cellular processes. Importantly, CLD demonstrates no significant toxicity on zebrafish embryos even at a concentration of 0.226 mM, indicating its potential as a safe biological-control agent. In summary, CLD would be a novel potential biological-control agent and can be considered as a promising fungicide to control B. cinerea.
- 3 August 2023
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (32) , 12190-12202
Discovery of a Natural Hybrid Polyketide Produced by Endophytic Cladosporium sphaerospermum for Biocontrol of Phytopathogenic Fungus Botrytis cinerea
The endophytic fungus Cladosporium sphaerospermum WBS017 exhibits broad-spectrum activity against plant pathogens, with particular effectiveness against Botrytis cinerea. Subsequently, a compound is isolated from strain WBS017 as the main active ingredient against B. cinerea using activity-guided separation and identified as hybrid polyketide (namely cladodionen, CLD) using UV, MS, NMR, etc. In vitro and in vivo antifungal activity tests demonstrate that CLD effectively inhibits the mycelial growth and spore germination, with an IC50 value of 1.13 and 0.095 mM, respectively, and exerts antifungal and fresh-keeping effects on both strawberry and tomato. Microscopy analysis reveals that the inhibitory effects of CLD on hyphae and spore germination are attributed to a decrease in structural stability of mycelia cells as well as the accumulation of reactive oxygen species (ROS). Furthermore, transcriptome analysis further indicates that spore germination is inhibited by suppressing the transcription levels of membrane or membrane-related genes, disturbing the balance of ROS metabolism, altering the primary metabolic pathways, genetic information processing, and cellular processes. Importantly, CLD demonstrates no significant toxicity on zebrafish embryos even at a concentration of 0.226 mM, indicating its potential as a safe biological-control agent. In summary, CLD would be a novel potential biological-control agent and can be considered as a promising fungicide to control B. cinerea.
- Open Access
- 17 September 2018
- Published by SAGE Publications in Lupus
- Vol. 27 (12) , 1898-1902
Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease
Monocytes play an important role in inducing host systemic immunity against invading pathogens and inflammatory responses. After activation, monocytes migrate to tissue sites, where they initiate both innate and adaptive immune responses, and become macrophages. Although mucosal macrophages produce inflammatory cytokines in response to pathogens, the perturbations in innate immune signaling pathway have been implicated in autoimmune diseases such as systemic lupus erythematosus (SLE). In this review, we focus on the role of human macrophages in intestinal innate immune responses, homeostasis, and SLE disease. We further discuss sex differences in the intestinal macrophages and their role in the physiology and pathogenesis of SLE.
- 17 September 2018
- Published by SAGE Publications in Lupus
- Vol. 27 (12) , 1898-1902
Open AccessIntestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease
Monocytes play an important role in inducing host systemic immunity against invading pathogens and inflammatory responses. After activation, monocytes migrate to tissue sites, where they initiate both innate and adaptive immune responses, and become macrophages. Although mucosal macrophages produce inflammatory cytokines in response to pathogens, the perturbations in innate immune signaling pathway have been implicated in autoimmune diseases such as systemic lupus erythematosus (SLE). In this review, we focus on the role of human macrophages in intestinal innate immune responses, homeostasis, and SLE disease. We further discuss sex differences in the intestinal macrophages and their role in the physiology and pathogenesis of SLE.